Status:
COMPLETED
The Effects of Anabolic Steroids and Protease Inhibitors on People Living With HIV/AIDS
Lead Sponsor:
Queen's University
Collaborating Sponsors:
Ontario Ministry of Health and Long Term Care
Conditions:
HIV
AIDS
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
The main aim of the study is to investigate the combined effects of using anabolic steroids and protease inhibitors on fat metabolism and body composition of People Living with HIV/AIDS. We are seeki...
Detailed Description
Changes in body composition and wasting have been a constant concern for people living with HIV/AIDS. Testosterone and its derivatives, anabolic steroids (AS) are being used by persons with HIV/AIDS (...
Eligibility Criteria
Inclusion
- documented HIV seropositive status
- 18 years of age or older
- combination antiretroviral therapies for at least three months or more
- able to comply with study procedures and protocol
- signed informed consent
Exclusion
- acute opportunistic infections at baseline
- use of serum lipid lowering drugs
- use of serum sugar controlling drugs
- evidence of drug or alcohol use which may interfere with study participation
- a recent illness with associate weight loss of greater than or equal to 10lbs
Key Trial Info
Start Date :
September 1 1999
Trial Type :
INTERVENTIONAL
End Date :
June 1 2001
Estimated Enrollment :
30 Patients enrolled
Trial Details
Trial ID
NCT00202241
Start Date
September 1 1999
End Date
June 1 2001
Last Update
January 13 2016
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Queen's University
Kingston, Ontario, Canada, K7L 3N6